SNHG12 and renal cell carcinoma: SNHG12 is a newly discovered biomarker of sunitinib resistance in recent years, and its underlying mechanism still needs to be further investigated, so as to provide a theoretical basis for clinical diagnosis, treatment and prognosis of RCC.